pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·3d ago·1 min read
save

Researchers may have to ‘revise a lot’ of theories about dementia after uncovering plastics in brain

Nov 16, 2026·read at Fierce Biotech ↗

The field of micro- and nanoplastics has drawn a lot of interest in recent years as concerns grow about the impact about contamination in the environment. These tiny plastic particles are created when plastic breaks down and are usually so small that they are invisible to the naked eye.

source

Reporting by Fierce Biotech.

read at Fierce Biotech ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 8h ago‘It’s a very healthy sector’: Biopharma gathers in London as M&A shines and China clouds loomFierce Biotech
  • 11h agoBausch + Lomb and Celldex rocked by respective phase 2 flopsFierce Biotech
  • 22h agoAnthropic board director Vas Narasimhan bets AI can help Novartis solve ‘biological latency’Fierce Biotech
  • 22h agoChutes & Ladders—Teva loses R&D head as innovation pivot advancesFierce Biotech
  • 1d agoVaccine biotech Evaxion halts infectious disease, autoimmune work to focus on oncologyFierce Biotech